TIS tissue therapies limited

RBS Morgans still have a 95 cent target.They say that the...

  1. 2,280 Posts.
    lightbulb Created with Sketch. 95
    RBS Morgans still have a 95 cent target.

    They say that the commercial partner will be the next bit of good news to come.

    They also say that the now confirmed FDA classification will probably extend the USA trials by 6 - 12 months.

    HOWEVER, they also say that their target price does NOT include the USA!

    Looks good going forward.

    Regards...............
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.